BATOR MICHAEL G. 4
4 · Cytosorbents Corp · Filed May 19, 2022
Insider Transaction Report
Form 4
BATOR MICHAEL G.
Director
Transactions
- Purchase
Common Stock
2022-05-18$2.18/sh+2,000$4,360→ 75,800 total - Purchase
Common Stock
2022-05-18$2.18/sh+2,000$4,360→ 77,800 total - Purchase
Common Stock
2022-05-18$2.20/sh+2,000$4,400→ 79,800 total - Purchase
Common Stock
2022-05-18$2.20/sh+2,000$4,400→ 81,800 total - Purchase
Common Stock
2022-05-18$2.20/sh+2,000$4,400→ 83,800 total - Purchase
Common Stock
2022-05-18$2.21/sh+1,000$2,210→ 84,800 total
Footnotes (1)
- [F1]Includes (a) the following restricted stock units which will vest upon a "Change of Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan: (i) 3,300 restricted stock units granted on March 15, 2018, (ii) 6,000 restricted stock units granted on February 24, 2017, and (iii) 60,000 restricted stock units granted on June 7, 2017, and (b) 15,500 shares of common stock owned by the reporting person, inclusive of 11,000 total shares of common stock purchased on May 18, 2022 and reported on this Form 4.